🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vivek Nagaraja

Michigan Medicine

ORCID: 0000-0002-6134-3387

Also affiliated with Mayo Clinic in Arizona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial”.

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30237-x
N/A
1.1DataRank · unranked
48 citations

Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor +27 more

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort

Arthritis Research & Therapy(2021)10.1186/s13075-021-02548-1
N/A
0.637DataRank · unranked
69 citations

Alain Lescoat, Suiyuan Huang, Jessica Gordon, Monique Hinchcliff, Ami A. Shah +15 more

Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA

Clinical and Experimental Rheumatology(2021)10.55563/clinexprheumatol/9ivp9g
N/A
0.442DataRank · unranked
18 citations

Mirette Habib, Sara Jaafar, Vivek Nagaraja, David Roofeh, Amber Young +3 more

Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment

Current Treatment Options in Rheumatology(2020)10.1007/s40674-020-00160-z
N/A
0DataRank · unranked
73 citations

Vanessa L. Kronzer, Paul F. Dellaripa, Kevin D. Deane, Marcy B. Bolster, Vivek Nagaraja +4 more

Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort

Lara D. Veeken(2022)10.1093/rheumatology/keac639
N/A
0DataRank · unranked
29 citations

Alain Lescoat, David Roofeh, Vivek Nagaraja, Rajaie Namas, Suiyuan Huang +7 more

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

Lara D. Veeken(2022)10.1093/rheumatology/keac557
N/A
0DataRank · unranked
17 citations

Kevin M. Brown, Ella A. Kazerooni, Donald P Tashkin, Shervin Assassi, Fernando J. Martínez +48 more